Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Eye Movement Training Efficacious for Hemianopic Patients
FRIDAY, Feb. 28, 2020 (HealthDay News) -- An eye movement training approach is efficacious for improving visual performance in hemianopic patients, according to a study published in the April issue of Cortex.
Influence of Politics Has Not Waned in Opinions About ACA
WEDNESDAY, Feb. 26, 2020 (HealthDay News) -- Public opinion about the Affordable Care Act (ACA) remains divided 10 years after its passage, according to a study published online Feb. 19 in Health Affairs.
Mistreatment, Discrimination Still Common for Medical Students
TUESDAY, Feb. 25, 2020 (HealthDay News) -- Mistreatment of medical students remains common for women, racial/ethnic minorities, and sexual minorities, according to a study published online Feb. 24 in JAMA Internal Medicine.
Many Transgender Youth Intentionally Avoid Disclosure
THURSDAY, Feb. 20, 2020 (HealthDay News) -- Most transgender youth voluntarily disclose their gender identity to health care providers (HCPs) outside of a gender clinic; however, almost half report having intentionally avoided disclosure, according to a study published online Feb. 20 in the Journal of Adolescent Health.
U.S. Life Expectancy to Reach 85 by 2060
FRIDAY, Feb. 14, 2020 (HealthDay News) -- Nearly a quarter of all U.S. residents will be older than 65 by 2060, and life expectancy will reach an all-time high of 85 by that year, according to the U.S. Census Bureau.
Telemarketer Access to Medicare Information to Be Investigated
FRIDAY, Feb. 14, 2020 (HealthDay News) -- An investigation into how telemarketers may be obtaining seniors' personal Medicare information will be launched by the U.S. Health and Human Services inspector general office.
Subconcussive Head Impacts May Affect Neuro-Ophthalmologic Function
THURSDAY, Feb. 13, 2020 (HealthDay News) -- Repetitive subconcussive head impacts may cause short-term impairment of neuro-ophthalmologic function, according to a study published online Feb. 13 in JAMA Ophthalmology.
2011 to 2018 Saw Decline in Problems Paying Medical Bills
WEDNESDAY, Feb. 12, 2020 (HealthDay News) -- From 2011 to 2018, there was a decrease in the percentage of families having problems paying medical bills in the past 12 months, according to a February data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
Broad Clinical Spectrum Linked to Pediatric MOG Antibodies
TUESDAY, Feb. 11, 2020 (HealthDay News) -- The spectrum of pediatric syndromes associated with myelin oligodendrocyte glycoprotein (MOG) antibodies is wider than previously thought, according to a study published online Feb. 10 in The Lancet Neurology.
Empathy Declines as Students Progress Through Medical School
MONDAY, Feb. 10, 2020 (HealthDay News) -- Students become less empathic toward patients throughout medical school, according to a study published online Jan. 21 in Academic Medicine.
Seniors Have Concerns About Affording Health Insurance
MONDAY, Feb. 10, 2020 (HealthDay News) -- Many adults aged 50 to 64 years are concerned about their ability to afford health insurance, according to a study published online Feb. 7 in JAMA Network Open.
Low-Contrast Sensitivity Predicts Poor Vision in Seniors
FRIDAY, Feb. 7, 2020 (HealthDay News) -- For older adults, low-contrast sensitivity is a predictor of experiencing poor vision, according to a study recently published online in Acta Ophthalmologica.
Reference Pricing Linked to Lower Prices Paid by Employers
THURSDAY, Feb. 6, 2020 (HealthDay News) -- Reference prices are associated with lower prices paid by employers and lower cost sharing by employees, according to a study published online Feb. 5 in JAMA Network Open.
Visit Adherence, Visual Acuity Linked in Macular Degeneration
THURSDAY, Feb. 6, 2020 (HealthDay News) -- Adherence to randomized clinical trial visits is associated with visual acuity in individuals with neovascular age-related macular degeneration, according to a study published online Feb. 6 in JAMA Ophthalmology.